GMCR up +1.66% percent right now. $GMCR High is at 156.51

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
GMCR up +1.66% percent right now. $GMCR High is at 156.51 and the Low 152.22 with current volume of 770,027.

Recent News posted below.

GMCR Keurig Green Mountain Inc. Recent Headline News

3 Analysts Reveal the Single Best Investments They Ever Made
Motley Fool Staff - Motley Fool - Sun Nov 09, 10:13AM CST
At The Motley Fool, we believe in a buy-and-hold strategy and trying to achieve steady market-beating returns over time. However, sometimes investments just turn out to be home runs. We asked three of our analysts to share a little bit about the...
GMCR: 154.48 (+1.58), CHKP: 74.94 (+0.27)

MTY Food Group and Keurig Canada Announce Agreement Taking Van Houtte-Branded Cafe-Bistros into New Era
Business Wire - Fri Nov 07, 2:00PM CST
MTY Food Group, Inc. (MTY) (TSX: MTY), franchisor and operator of multiple concepts of quick service restaurants, and Keurig Canada Inc., a subsidiary of Keurig Green Mountain, Inc. (Keurig) (NASDAQ: GMCR), a leader in specialty coffee, coffee makers, teas and other beverages with its innovative brewing technology, today announced the companies have reached an agreement regarding the Van Houtte Cafe-Bistros franchise network. Under the terms of the agreement, Keurig Canada will maintain ownership of the Van Houtte brand, image, and wholesale business, while MTY will own and operate Van Houtte Cafe-Bistros, taking them into a new era of great food and beverage service.
GMCR: 154.48 (+1.58), MTY.TO: 33.01 (+0.45)

MTY Food Group and Keurig Canada Announce Agreement - Taking Van Houtte-Branded Café-Bistros into New Era
CNW Group - Fri Nov 07, 2:00PM CST
MTY Food Group, Inc. (MTY) (TSX: MTY), franchisor and operator of multiple concepts of quick service restaurants, and Keurig Canada Inc., a subsidiary of Keurig Green Mountain, Inc. (Keurig) (NASDAQ: GMCR), a leader in specialty coffee, coffee makers, teas and other beverages with its innovative brewing technology, today announced the companies have reached an agreement regarding the Van Houtte Café-Bistros franchise network. Under the terms of the agreement, Keurig Canada will maintain ownership of the Van Houtte brand, image, and wholesale business, while MTY will own and operate Van Houtte Café-Bistros, taking them into a new era of great food and beverage service.
GMCR: 154.48 (+1.58), MTY.TO: 33.01 (+0.45)

Fred's October Sales Slow Down, Warmer Weather to Blame - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 1:56PM CST
Fred's Inc. (FRED) reported a 1.3% year-over-year decline in comparable-store sales (comps) in Oct 2014. It compared unfavorably with 0.9% increase in the year-ago period due to weak retail environment and low consumer spending.
DLTR: 61.85 (+0.29), GMCR: 154.48 (+1.58), FRED: 15.88 (-0.43), ROST: 82.01 (+0.60)

Cramer: Coca-Cola Needs to Buy Monster Beverage, Keurig Green Mountain
at The Street - Fri Nov 07, 10:36AM CST
Cramer said Coca-Cola needs Monster Beverage and Keurig Green Mountain if it wants to grow and make shareholders happy.
KO: 42.43 (+0.11), MNST: 106.90 (-1.49), GMCR: 154.48 (+1.58)

Green Mountain Coffee Roasters Has Returned 15.8% Since SmarTrend Recommendation (GMCR)
Comtex SmarTrend(R) - Thu Nov 06, 9:23AM CST
SmarTrend identified an Uptrend for Green Mountain Coffee Roasters (NASDAQ:GMCR) on August 22nd, 2014 at $130.70. In approximately 3 months, Green Mountain Coffee Roasters has returned 15.77% as of today's recent price of $151.31.
GMCR: 154.48 (+1.58)

Green Mountain Coffee Roasters Set to Possibly Rebound After Yesterday's Selloff of 1.08%
Comtex SmarTrend(R) - Wed Nov 05, 4:15PM CST
Green Mountain Coffee Roasters (NASDAQ:GMCR) traded in a range yesterday that spanned from a low of $149.75 to a high of $153.90. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $151.00 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GMCR: 154.48 (+1.58)

SmarTrend Watching for Potential Rebound in Shares of Green Mountain Coffee Roasters After 1.08% Loss
Comtex SmarTrend(R) - Wed Nov 05, 4:14PM CST
Green Mountain Coffee Roasters (NASDAQ:GMCR) traded in a range yesterday that spanned from a low of $149.75 to a high of $153.90. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $151.00 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GMCR: 154.48 (+1.58)

The 1 Thing That Would Make Me Sell PepsiCo, Inc. Stock
Bob Ciura, The Motley Fool - Motley Fool - Wed Nov 05, 2:54PM CST
PepsiCo has a long and storied history of rewarding shareholders. The company racks up solid growth year in and year out, and pays a nice dividend to shareholders. PepsiCo's results this year once again prove what a strong business it is, and...
KO: 42.43 (+0.11), MNST: 106.90 (-1.49), GMCR: 154.48 (+1.58), PEP: 96.89 (+0.09)

20 Stocks That Could Beat the Market in November: Priceline, U.S. Steel Lead Way
at The Street - Wed Nov 05, 10:24AM CST
Which stocks have historically done the best in November, typically one of the best months to invest?
BIIB: 324.59 (+3.84), MNST: 106.90 (-1.49), ATI: 31.47 (-1.21), MON: 115.66 (+1.22), GMCR: 154.48 (+1.58), VMC: 65.20 (+0.09), EMR: 65.09 (+0.23), WDC: 97.12 (-0.58), VRSN: 60.36 (+0.56), URBN: 30.61 (-0.57), FSLR: 51.93 (+1.64), DE: 88.63 (-0.03), EXPE: 85.99 (+0.88), FLR: 65.91 (-0.38), FLS: 68.05 (+0.15), X: 36.93 (-0.64), ROK: 112.28 (-0.01), REGN: 382.57 (+4.73), MA: 84.70 (-0.10)

4 Reasons PepsiCo Can't Save SodaStream International
Rich Duprey, The Motley Fool - Motley Fool - Wed Nov 05, 9:00AM CST
Not even SodaStream partnering with PepsiCo can keep the do-it-yourself beverage specialist from going flat. Plunging sales, a growing consumer trend of avoiding its primary product, and a controversially sited bottling plant can't be...
SBUX: 77.73 (-0.06), KO: 42.43 (+0.11), GMCR: 154.48 (+1.58), CPB: 44.35 (+0.25), KRFT: 57.98 (+0.11), SODA: 21.67 (-0.33), PEP: 96.89 (+0.09)

Critical Alerts For Office Depot, Rockwell Medical, Estee Lauder, Discovery Communications and Keurig Green Mountain Released By InvestorsObserver
PR Newswire - Wed Nov 05, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for ODP, RMTI, EL, DISCA and GMCR.
GMCR: 154.48 (+1.58), DISCA: 32.29 (-0.33), ODP: 6.50 (unch), RMTI: 10.53 (-0.02), EL: 72.85 (+0.27)

Quarterly Earnings, New Product, and Expansion - Research Reports on Tempur Sealy, Mead Johnson, Keurig, Mattel and Colgate
PR Newswire - Wed Nov 05, 8:05AM CST
Today, Analysts Review released its research reports regarding Tempur Sealy International Inc. (NYSE: TPX), Mead Johnson Nutrition Company (NYSE: MJN), Keurig Green Mountain, Inc. (NASDAQ: GMCR), Mattel, Inc. (NASDAQ: MAT) and Colgate-Palmolive Co. (NYSE: CL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7707-100free.
MJN: 99.17 (+0.78), MAT: 31.57 (-0.10), GMCR: 154.48 (+1.58), TPX: 54.93 (+0.38), CL: 68.35 (+0.30)

Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 49.18 (+2.04), MNST: 106.90 (-1.49), SWKS: 60.63 (+0.75), GMCR: 154.48 (+1.58), ILMN: 189.06 (+2.71), WSM: 66.44 (+0.56), NXPI: 74.34 (+0.80), CELG: 107.69 (+1.24), HAIN: 108.49 (+0.81), AGN: 195.86 (-0.14), CNC: 92.94 (+1.22), V: 249.27 (-3.16), CALM: 42.31 (-0.72), JAZZ: 172.68 (+1.88), ALXN: 194.00 (+0.19), LOW: 57.84 (+0.15), ULTA: 122.28 (+0.53), MA: 84.70 (-0.10), AVGO: 85.41 (+0.37), PETM: 72.57 (+0.03)

Diageo Ups Tequila Presence with Don Julio, Sells Bushmills - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:19PM CST
U.K.-based brewer Diageo plc (DEO) recently inked a deal with the owners of Tequila Cuervo la Rojena SA de CV to gain full control of the tequila brand Don Julio.
MNST: 106.90 (-1.49), GMCR: 154.48 (+1.58), SAM: 260.75 (+1.85), DEO: 117.89 (+1.59)

The True Story of How Starbucks Went From a Single Store to a Coffee Giant
Dan Caplinger, The Motley Fool - Motley Fool - Sun Nov 02, 9:15AM CST
Original Starbucks store. Source: Starbucks. No matter where you are, it's hard to go far without seeing a Starbucks selling coffee to large crowds, with lines running outside buildings during peak times. Yet like every other big business in...
SBUX: 77.73 (-0.06), DNKN: 47.04 (unch), GMCR: 154.48 (+1.58), MCD: 95.23 (+0.13)

41 Billionaires: Meet the Richest Person in Every U.S. State
at The Street - Sat Nov 01, 9:11AM CDT
No matter where you live, there's someone living nearby who is richer than you are -- unless you're on this new list out from Wealth-X.
CLR: 55.26 (+0.13), CCL: 40.17 (-0.23), NKE: 94.77 (+0.99), GMCR: 154.48 (+1.58), WMT: 79.83 (+1.06), LVS: 59.55 (+0.02), ORCL: 40.47 (+0.53), DISH: 63.53 (-0.18), HUN: 24.76 (+0.07), HCA: 67.38 (+1.63), LB: 76.04 (+0.43), BRK.B: 144.59 (+0.98), MSFT: 49.04 (+0.36)

Green Mountain Coffee Roasters Set to Possibly Pullback After Yesterday's Rally of 1.18%
Comtex SmarTrend(R) - Fri Oct 31, 4:23PM CDT
Green Mountain Coffee Roasters (NASDAQ:GMCR) traded in a range yesterday that spanned from a low of $151.14 to a high of $155.09. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $150.62 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GMCR: 154.48 (+1.58)

Look for Shares of Green Mountain Coffee Roasters to Potentially Pullback after Yesterday's 1.18% Rise
Comtex SmarTrend(R) - Fri Oct 31, 4:22PM CDT
Green Mountain Coffee Roasters (NASDAQ:GMCR) traded in a range yesterday that spanned from a low of $151.14 to a high of $155.09. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $150.62 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GMCR: 154.48 (+1.58)

AB InBev Q3 Earnings Miss Estimates but Up Y/Y, View Intact - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 11:30AM CDT
Anheuser-Busch InBev SA/NV (BUD), also known as AB InBev, posted mixed results for third-quarter 2014, wherein both top and bottom lines marked a year-over-year improvement but fell short of the Zacks Consensus Estimate.
DPS: 70.30 (+0.35), MNST: 106.90 (-1.49), BUD: 109.38 (+1.04), GMCR: 154.48 (+1.58)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading